ESMO Open

39.0k citations
2.7k papers · · active since 2016

Impact in

  • Oncology top 5%
    • Cancer Immunotherapy and Biomarkers
    • Colorectal Cancer Treatments and Studies
    • HER2/EGFR in Cancer Research
    • Lung Cancer Research Studies
    • Pancreatic and Hepatic Oncology Research
    • COVID-19 and healthcare impacts
    • Cancer Genomics and Diagnostics

Papers in

    • Cancer Immunotherapy and Biomarkers 264
    • HER2/EGFR in Cancer Research 173
    • Colorectal Cancer Treatments and Studies 173
    • Cancer Treatment and Pharmacology 142
    • Cancer Genomics and Diagnostics 182
    • Breast Cancer Treatment Studies 157

ESMO Open

1.9k papers receiving 33.8k citations

Peers

ESMO Open
Comparison fields: 5 of 175
  • Oncology 17.4k
  • Cancer Research 4.8k
  • Pulmonary and Respiratory Medicine 9.2k
  • Immunology 2.9k
  • Pathology and Forensic Medicine 2.3k
Replace Therapeutic Advances in Medical Oncology with:
Therapeutic Advances in Medical Oncology China
Current Oncology Canada
Cancer Control United States
American Society of Clinical Oncology Educational Book United States
Clinical & Translational Oncology Spain
Cancer Research and Treatment South Korea
The Cancer Journal United States
Journal of Oncology China
Cancer treatment and research United States
Recent results in cancer research Germany
ESMO Open relative to Therapeutic Advances in Medical Oncology China Therapeutic Advances in Medical Oncology's profile →
Citations per field
00.5×1.5×2×2.3×
Therapeutic Advances in Medical Oncology · 1×
Citations per year

Countries where authors publish in ESMO Open

Since Specialization
Citations

This map shows the geographic impact of research published in ESMO Open. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers published in ESMO Open with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites ESMO Open more than expected).

Fields of papers published in ESMO Open

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers published in ESMO Open. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers published in ESMO Open.

About ESMO Open

The 2.7k papers published in ESMO Open in the last decades have received a total of 39.0k indexed citations . Papers published in ESMO Open usually cover Oncology (1.2k papers), Cancer Research (381 papers), Pulmonary and Respiratory Medicine (766 papers), Otorhinolaryngology (36 papers) and Reproductive Medicine (62 papers) specifically the topics of Cancer Immunotherapy and Biomarkers (264 papers), Lung Cancer Treatments and Mutations (240 papers), Advanced Breast Cancer Therapies (230 papers), Cancer Genomics and Diagnostics (182 papers), HER2/EGFR in Cancer Research (173 papers), Colorectal Cancer Treatments and Studies (173 papers), Breast Cancer Treatment Studies (157 papers) and Cancer Treatment and Pharmacology (142 papers). The most active scholars publishing in ESMO Open are Salvatore Siena, Andrea Sartore Bianchi, Alessio Amatu, Evandro de Azambuja, Floriana Morgillo, Carminia Maria Della Corte, Matteo Lambertini, Fortunato Ciardiello, Matthias Preusser and Morena Fasano.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore journals with similar magnitude of impact